A detailed history of Bogart Wealth, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Bogart Wealth, LLC holds 209 shares of BIIB stock, worth $33,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares
209
Previous 209 -0.0%
Holding current value
$33,001
Previous $48,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$190.52 - $236.72 $1,524 - $1,893
-8 Reduced 3.69%
209 $48,000
Q1 2024

Apr 25, 2024

SELL
$212.02 - $267.71 $2,332 - $2,944
-11 Reduced 4.82%
217 $46,000
Q3 2023

Oct 30, 2023

BUY
$253.3 - $285.89 $2,026 - $2,287
8 Added 3.64%
228 $58,000
Q2 2023

Jul 28, 2023

BUY
$275.25 - $318.06 $5,505 - $6,361
20 Added 10.0%
220 $62,000
Q2 2022

Jul 22, 2022

BUY
$187.54 - $223.02 $34,507 - $41,035
184 Added 1150.0%
200 $41,000
Q1 2022

Apr 22, 2022

SELL
$193.77 - $244.14 $1,356 - $1,708
-7 Reduced 30.43%
16 $3,000
Q4 2021

Jan 19, 2022

BUY
$223.92 - $287.77 $4,030 - $5,179
18 Added 360.0%
23 $6,000
Q3 2021

Oct 15, 2021

SELL
$282.99 - $369.05 $2,829 - $3,690
-10 Reduced 66.67%
5 $1,000
Q2 2021

Aug 06, 2021

SELL
$259.0 - $414.71 $259 - $414
-1 Reduced 6.25%
15 $5,000
Q1 2021

Apr 16, 2021

BUY
$242.95 - $284.63 $971 - $1,138
4 Added 33.33%
16 $4,000
Q4 2020

Jan 14, 2021

SELL
$236.26 - $355.63 $536,310 - $807,280
-2,270 Reduced 99.47%
12 $2,000
Q3 2020

Oct 06, 2020

BUY
$264.77 - $305.71 $116,498 - $134,512
440 Added 23.89%
2,282 $647,000
Q2 2020

Jul 08, 2020

BUY
$258.66 - $342.55 $85,357 - $113,041
330 Added 21.83%
1,842 $493,000
Q1 2020

Apr 20, 2020

BUY
$268.85 - $341.04 $77,697 - $98,560
289 Added 23.63%
1,512 $478,000
Q4 2019

Feb 10, 2020

BUY
$220.06 - $304.07 $14,523 - $20,068
66 Added 5.7%
1,223 $363,000
Q3 2019

Oct 10, 2019

BUY
$217.44 - $243.88 $19,134 - $21,461
88 Added 8.23%
1,157 $269,000
Q2 2019

Jul 11, 2019

BUY
$219.29 - $241.72 $58,331 - $64,297
266 Added 33.13%
1,069 $250,000
Q1 2019

Apr 08, 2019

BUY
$216.71 - $338.96 $174,018 - $272,184
803 New
803 $189,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bogart Wealth, LLC Portfolio

Follow Bogart Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.